The company’s financial results, reported under IFRS accounting standards, highlight a period of diverging performance. While total revenue rose to ¥127.14 billion from ¥121.32 billion, this top-line growth failed to translate into higher earnings. Operating profit saw a slight contraction, settling at ¥32.33 billion compared to ¥32.75 billion in the previous year.
In section Market Quotes
Nippon Shinyaku Net Profit Falls to ¥25.8B Despite Revenue Growth
Nippon Shinyaku Co. Ltd. reported a decline in net profit for the first nine months of its fiscal year, even as the Japanese drugmaker saw its total revenue climb. For the period ending December 31, the company reported a net profit of ¥25.84 billion, down from the ¥28.55 billion recorded during the same timeframe a year earlier.
Financial Performance Breakdown
Pretax figures followed a similar downward trend, reaching ¥33.23 billion against the prior year's ¥33.44 billion. The squeeze on margins resulted in diluted earnings per share falling to ¥383.50, down from ¥423.84 in the prior period, according to the company's financial statement.The nine-month performance indicators for the Kyoto-based firm include:
- Group revenue increased by approximately 4.8% to ¥127.14 billion.
- Net profit attributable to the company fell by nearly 9.5% year-over-year.
- Operating profit margins tightened slightly to approximately 25.4%.
Comments (0)
No comments yet. Be the first!